Retension Pharmaceuticals, Inc. (RTSN) SEC filings
RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 18, 2026
$11.41−0.05 (-0.44%)
Close on Nov 17, 2026Market cap $9.22MP/E –Yield –
SEC filings
4 of Retension Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 18, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2026 | Nov 18, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2026 | Oct 23, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2026 | Oct 13, 2026 | SEC EDGAR |
See a number that looks wrong?